FDA And EMEA To Compare Regulatory Approaches Used In 1998 NME Cohort
Executive Summary
FDA and the European Medicines Evaluation Agency will conduct a joint assessment of the approaches used by the two agencies in the 1998 cohort of new molecular entity reviews.